SIRT6 protein levels are decreased and ACSL5 K361 acetylation levels are increased in the liver of nonalcoholic steatohepatitis (NASH) patients compared to those in healthy controls [16]. This evidence concerns the gene ACSL5 and metabolic dysfunction-associated steatohepatitis.